This episode looks at insulin resistance and chronic inflammation, the two way cycle where each condition makes the other worse, and what current research says about mesenchymal stem cell therapy as a way to help calm that cycle.
You'll learn:
- How inflammation in visceral fat tissue blocks insulin from working properly in the liver, muscle, and fat
- Why immune cells called macrophages release TNF-alpha and IL-6 and spread inflammation through the bloodstream
- How mesenchymal stem cells may calm an overactive immune response through paracrine signaling rather than by replacing tissue
- What a 2022 randomized, placebo controlled trial from Beijing found in adults with type 2 diabetes
- How Cyrona Cell sources and screens its umbilical cord derived WJMSCs under BSL2, CGMP, and ISO 9001 standards
- Why type 1 and type 2 diabetes involve different root causes and different treatment goals
- How physical activity, sleep, and stress management continue to shape insulin resistance outcomes
- What typically makes someone a good candidate for this kind of therapy
Insulin resistance and inflammation often move together, and understanding that link is a useful starting point before looking at any treatment option. For the full breakdown, follow the link below.
Blog Link: Inflammation and Insulin Resistance: Can Stem Cells Help?
